The risk of developing hepatitis C aftertransplantation in patients was shown to be associated with the frequency ofthe SNP rs868 located in the non-coding 3′-UTR region of the TGF-β1receptor gene (Tgfbr1) [21]. Here, TGFBR1 is linked to hepatitis C virus infection.